Inventor · disambiguated record
Nicolas Barthelemy
Also filed as: BARTHELEMY NICOLAS
4 granted patents·6 pending applications·9 citations·filing 2020–2023
68Inventor score
Top patents by PatentIndex Score
10 records- 0191US11085935B2Methods of treating based on site-specific tau phosphorylationUNIV WASHINGTON·Filed 2020·Granted Aug 10, 2021·6 cites·20 claims
- 0287US11402392B2Methods of treating based on site-specific tau phosphorylationUNIV WASHINGTON·Filed 2021·Granted Aug 2, 2022·2 cites·28 claims
- 0385US11635440B2Methods of treating based on site-specific tau phosphorylationWASHINGTON UNIVERSITY ST LOUIS·Filed 2022·Granted Apr 25, 2023·1 cites·30 claims
- 0477US2023341421A1Methods of treating based on site-specific tau phosphorylationWASHINGTON UNIVERSITY ST LOUIS·Filed 2023·Application pending·0 cites
- 0556US2023280357A1Csf phosphorylated tau and amyloid beta profiles as biomarkers of tauopathiesWASHINGTON UNIVERSITY ST LOUIS·Filed 2022·Application pending·0 cites
- 0653US2025147049A1Methods for detecting csf tau species with stage and progression of alzheimer's disease, and use thereofWASHINGTON UNIVERSITY ST LOUIS·Filed 2022·Application pending·0 cites
- 0753US2022064271A1Methods for treating tauopathiesUNIV WASHINGTON·Filed 2021·Application pending·0 cites
- 0849US12493043B2Blood-based assay for diagnosing and treating based on site-specific tau phosphorylationWASHINGTON UNIVERSITY ST LOUIS·Filed 2020·Granted Dec 9, 2025·0 cites·20 claims
- 0947US2022299527A1Methods to detect mtbr tau isoforms and use thereofUNIV WASHINGTON·Filed 2020·Application pending·0 cites
- 1047US2023132508A1Uses of Tau Phosphosites as Biomarkers for Alzheimer's DiseaseGENENTECH INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicolas Barthelemy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →